Skip Navigation

European Heart Journal 2002 23(4):274-276; doi:10.1053/euhj.2001.2829
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brener, S.J.
Right arrow Articles by Topol, E.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brener, S.J.
Right arrow Articles by Topol, E.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Epicardial versus microcirculatory dissociation

S.J. Brener and E.J. Topol

The Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A.

References

  1. Nishida T, Di Mario C, Kern MJ. Impact of final coronary flow velocity reserve on late outcome following stent implantation. Eur Heart J. 2002;23:331–340[Abstract/Free Full Text]
  2. Topol EJ, Mark DB, Lincoff AM. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet. 1999;354:2019–2024[CrossRef][Web of Science][Medline]
  3. Herrmann J, Haude M, Lerman A. Abnormal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation. Circulation. 2001;103:2339–2345[Abstract/Free Full Text]
  4. Serruys PW, de Bruyne B, Carlier S. Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement. Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) II Study Group. Circulation. 2000;102:2930–2937[Abstract/Free Full Text]
  5. Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol. 2000;35:922–928[Abstract/Free Full Text]
  6. Biasucci LM, Liuzzo G, Angiolillo DJ, Sperti G, Maseri A. Inflammation and acute coronary syndromes. Herz. 2000;25:108–112[CrossRef][Web of Science][Medline]
  7. Folts J. An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis. Circulation. 1991;83:IV3–14
  8. Neumann FJ, Zohlnhofer D, Fakhoury L, Ott I, Gawaz M, Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol. 1999;34:1420–1426[Abstract/Free Full Text]
  9. Neumann FJ, Hochholzer W, Pogatsa-Murray G, Schomig A, Gawaz M. Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting. J Am Coll Cardiol. 2001;37:1323–1328[Abstract/Free Full Text]
  10. Lincoff AM, Kereiakes DJ, Macelli MA. Abciximab suppresses the rise in plasma levels of inflammatory markers following PTCA. Circulation. 2001;104:163–167[Abstract/Free Full Text]
  11. Walter DH, Fichtlscherer S, Britten MB. Initiation of statin therapy immediately after stent implantation: profound benefit in patients with acute coronary syndromes. Circulation. 2000;:

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 HeartHome page
G S Werner, U Emig, P Bahrmann, M Ferrari, and H R Figulla
Recovery of impaired microvascular function in collateral dependent myocardium after recanalisation of a chronic total coronary occlusion
Heart, November 1, 2004; 90(11): 1303 - 1309.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brener, S.J.
Right arrow Articles by Topol, E.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brener, S.J.
Right arrow Articles by Topol, E.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?